IQ-AI - Imaging Biometrics
@iqai_ib
Clinically-validated, sophisticated and intuitive tumor analysis software solutions for clinicians and researchers.
ID: 1115377008907829250
http://www.imagingbiometrics.com 08-04-2019 22:12:56
764 Tweet
613 Followers
419 Following
        Kudos to Imaging Biometrics co-founder Dr. Kathleen Schmainda and collaborators for continuing to advance the field of MR imaging for #braintumor patients. IB Neuro's exclusive standardized rCBV (DSC perfusion) is automated and eliminates manual ROI-based tissue normalization -
        This kind of patient-driven advocacy helps accelerate change. Thank you for spotlighting Imaging Biometrics' FTB maps! The American Society of Neuroradiology SNO American Brain Tumor Association Al Musella National Brain Tumor Society CNS "Changing the standard of care for Glioblastoma. Itās time for an update. FTB, Fractional Tumor
        Imaging Biometrics' exclusive, quantitative, and automated Delta T1 maps are redefining neuro-oncology imaging. No more signal ambiguity. Just high-fidelity contrast assessment. A leading neuro-radiologist breaks down why conventional imaging is no longer optional. "During image
        
        
        $IBAI Imaging Biometrics strikes deal to commercialise advanced brain scan software tinyurl.com/ysn2q5jh Imaging Biometrics $5Y1 $IQAIF #IBAI #5Y1 #IQAIF
        
        Erik Middlebrooks, MD kicks off the #fMRI #brainmapping course at American Society of Functional Neuroradiology #ASFNR25 with Prism Clinical Imaging available to hands-on abs virtual attendees!
        
        
        
        
        Repeatability matters in brain tumor imaging. Same patient. 2 MR perfusion scans. 3 days apart. No intervening treatment. Which would you trust for treatment decisions? The American Society of Neuroradiology SNO American Brain Tumor Association National Brain Tumor Society
                        
                    
                    
                    
                
        Weāre proud to share that Imaging Biometrics' co-founder, Professor Kathleen Schmainda, will be opening the St. Jude Research seminar on Advanced Neuroimaging in Pediatric Brain Tumors. Her pioneering work continues to shape the future of precision imaging in oncology. Oct 30 - Nov 2
        Visit Prism Clinical Imaging at #2025CNS Booth 457 to learn how Imaging Biometrics' FTB maps are transforming #Neurosurgery. Integrated with Prismās suite, IBās automated mapping improves surgical planning, biopsy targeting & treatment decisionsābacked by recent clinical studies. CNS
                        
                    
                    
                    
                
        We'll be there with #brainmapping tools from Prism Clinical Imaging, Imaging Biometrics, and Sora Neuroscience!
        Echoing the enthusiasmā Imaging Biometrics is excited for this partnership with Vivan Therapeutics! linkedin.com/posts/hub71ad_ā¦
        
        š October Highlights ⢠Dr. Kathleen Schmainda opens St. Judeās Pediatric Neuro-Oncologic Imaging Course š ⢠FDA-cleared QSMetric⢠now availableāquantifying iron, hemorrhage & neuroinflammation for MS, DBS, CCM & glioma 𧲠⢠š§ Join Dr. Max Krucoffās Nov 19 webinar on